Feasibility Evaluation of Myocardial Cannabinoid Type 1 Receptor Imaging in Obesity: A Translational Approach
Conclusions
Noninvasive imaging of cardiac CB1-R expression in obesity is feasible applying [11C]-OMAR and PET/CT. These results may provide a rationale for further clinical testing of CB1-R-targeted molecular imaging in cardiometabolic diseases.
Source: Journal of the American College of Cardiology: Cardiovascular Imaging - Category: Radiology Authors: Valenta, I., Varga, Z. V., Valentine, H., Cinar, R., Horti, A., Mathews, W. B., Dannals, R. F., Steele, K., Kunos, G., Wahl, R. L., Pomper, M. G., Wong, D. F., Pacher, P., Schindler, T. H. Tags: Original Research Source Type: research
More News: Cardiology | Cardiomyopathy | Cardiovascular | CT Scan | Diabetes | Diabetes Type 1 | Eating Disorders & Weight Management | Endocrinology | Genetics | Heart | Obesity | Radiology | Study